Gear Up for Aveanna (AVAH) Q2 Earnings: Wall Street Estimates for Key Metrics

Besides Wall Street's top-and-bottom-line estimates for Aveanna (AVAH), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2026.

Zacks Investment Research • Aug 10, 2026

Is the Options Market Predicting a Spike in Aveanna Healthcare Stock?

Investors need to pay close attention to AVAH stock based on the movements in the options market lately.

Zacks Investment Research • Aug 10, 2026

Will Lower PDS Margin Affect Aveanna Healthcare's Q2 Earnings?

AVAH's Q2 revenues are expected to rise 9.8%, but lower PDS margins and higher costs may weigh on earnings.

Zacks Investment Research • Aug 10, 2026

AVAH vs. CHE: Which Stock Should Value Investors Buy Now?

Investors interested in Medical - Outpatient and Home Healthcare stocks are likely familiar with Aveanna Healthcare (AVAH) and Chemed (CHE). But which of these two stocks presents investors with the better value opportunity right now?

Zacks Investment Research • Aug 5, 2026

Best Cheap Stocks Under $10 to Buy Now in August

Investors might want to start buying best-in-class, cheap stocks trading under $10 a share as the market soars to start August.

Zacks Investment Research • Aug 4, 2026

4 GARP Stocks With Discounted PEG Ratios and Strong Growth to Buy Now

Centene joins three other GARP picks with discounted PEG ratios and solid long-term growth potential. See what puts these stocks on the list.

Zacks Investment Research • Aug 3, 2026

Should Value Investors Buy Aveanna Healthcare (AVAH) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Investment Research • Jul 29, 2026

3 Stocks Showing Breakout Potential Ahead of August

Breakout stocks BSET, AVAH and IART are trading near 52-week highs after passing technical screens. See why they could outperform in August.

Zacks Investment Research • Jul 29, 2026

Why Fast-paced Mover Aveanna (AVAH) Is a Great Choice for Value Investors

Aveanna (AVAH) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.

Zacks Investment Research • Jul 27, 2026

Top Healthcare Stocks Beyond The Market Rotation Averaging 128% Forward EPS Growth

Healthcare stocks have outperformed in the past month amid a rotation away from the AI trade and other risk-on investments. Global fund managers increased positions in healthcare more than any other sector or asset, according to Bank of America's July survey. In volatile markets, investors tend to pivot to defensive sectors, and healthcare has been a top performer during periods of uncertainty, including ahead of November's U.S. midterm elections.

Seeking Alpha • Jul 24, 2026